CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President, Cerus Europe acquired 25,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 19,500 shares at $4.95 ($96,504)
- 4 Open-market buy Chief Scientific Officer bought 25,900 shares at $4.99 ($129,233)
- 4 Open-market buy Chief Scientific Officer bought 84,600 shares at an average $4.77 ($403,465)
- 4 Open-market buy Chief Scientific Officer bought 50,000 shares at $4.98 ($249,045)
- 4 Open-market buy Chief Scientific Officer bought 25,000 shares at $4.82 ($120,550)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President, Cerus Europe acquired 25,000 shares (option exercise)
Page 20 of 36 · 701 filings